Burden of disease and economic evaluation of healthcare interventions: Are we investigating what really matters?

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Catal Lápez, Ferrn ^a,b   García Altés, Anna ^b,c   Álvarez Martín, Elena ^d   Gènova Maleras, Ricard ^e   Morant Ginestar, Consuelo ^e   Parada, Antoni ^c  

^a Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^b Fundacion Instituto de Investigacion en Servicios de Salud   (Spain)

^c Catalan Agency for Health Information   (Spain)

^d UNIVERSIDAD REY JUAN CARLOS   (Spain)

^e Regional Health Council   (Spain)

Author keywords

Cost of illness; Cost benefit analysis; Disability adjusted life years; Health economics; Spain

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DAILY LIFE ACTIVITY; ECONOMICS; HEALTH CARE COST; HEALTH SERVICE; HEALTH SERVICES RESEARCH; HUMAN; LIFE EXPECTANCY; QUALITY ADJUSTED LIFE YEAR; SPAIN; STATISTICS;

ACTIVITIES OF DAILY LIVING; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES; HEALTH SERVICES RESEARCH; HUMANS; LIFE EXPECTANCY; QUALITY-ADJUSTED LIFE YEARS; SPAIN;

EID: 84855176120     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-75     Document Type: Article

References (34)

1. Twenty years of health care economic analysis in Spain: are we doing well? A García-Altés, Health Econ 2001 10 715 29 11747053 (Pubitemid 34041385)
2. Economic evaluation of healthcare interventions during more than 25 years in Spain (1983-2008). F Catal-Lápez A García-Altés, Rev Esp Salud Pblica 2010 84 4 353 369
3. The global burden of disease. CJL Murray A Lápez, Cambridge: Harvard University Press 1996
4. The global burden of disease: 2004 update. World Health Organization, Geneva: World Health Organization 2008
5. The relation between funding by the National Institutes of Health and the burden of disease. CP Gross GF Anderson NR Powe, N Engl J Med 1999 340 24 1881 7 10.1056/NEJM199906173402406 10369852 (Pubitemid 29272669)
6. NIH funding trajectories and their correlations with U.S. health dynamics from 1950 to 2004. KG Manton XL Gu G Lowrimore A Ullian HD Tolley, Proc Natl Acad Sci USA 2009 106 27 10981 10986 10.1073/pnas.0905104106 19549852
7. Health burden and funding at the Centers for Disease Control and Prevention. CW Curry AK De RM Ikeda SB Thacker, Am J Prev Med 2006 30 3 269 76 10.1016/j.amepre.2005.10.028 16476645 (Pubitemid 43221964)
8. WHO's budgetary allocations and burden of disease: a comparative analysis. D Stuckler L King H Robinson M McKee, Lancet 2008 372 9649 1563 69 10.1016/S0140-6736(08)61656-6 18984189
9. Relationship between research funding in the Spanish National Health System and the burden of disease. F Catal Lápez E Álvarez Martín R Gènova Maleras C Morant Ginestar, Rev Esp Salud Pblica 2009 83 137 51 http://www.msc.es/biblioPublic/publicaciones/recursos-propios/ resp/revista-cdrom/vol83/vol83-1/RS831C-137ingles.pdf Available at [in English]: [accessed July 2, 2010]
10. Can we better prioritize resources for cost-utility research? PJ Neumann AB Rosen D Greenberg NV Olchanski R Pande RH Chapman PW Stone S Ondategui-Parra J Nadai JE Siegel MC Weinstein, Med Decis Making 2005 25 4 429 36 10.1177/0272989X05276853 16061895 (Pubitemid 41023170)
11. Analysis of economic evaluations of health technologies performed in Spain between 1990 and 2000. J Oliva J Del Llano JA Sacristn, Gac Sanit 2002 16 2 2 11 15826599
12. Health promotion: a profitable investment? Economic efficiency of preventive interventions in Spain. A Esperato A García-Altés, Gac Sanit 2007 21 2 150 61 10.1157/13101044 17419933
13. Development of a geographic filter for PubMed to identify studies performed in Spain. JM Valderas J Mendivil A Parada M Losada-Ỹez J Alonso, Rev Esp Cardiol 2006 59 12 1244 51 10.1157/13096592 17194419 (Pubitemid 46188823)
14. Burden of disease and morbidity trends of the Spanish population. R Gènova Álvarez C Morant, Ageing and dependency. A look at the future landscape of the Spanish population Madrid: Mondiale Assistance, Puyol R, Abelln A, 2006 6 107 24
15. Summary measures of population health: concepts, ethics, measurement and applications. CJL Murray JA Salomon CD Mathers AD Lopez, Geneva: World Health Organization 2002
16. Population as of July 2006. Estimations of the current population. National Statistics Institute (Instituto Nacional de Estadística - INE), Madrid: INE 2008 http://www.ine.es/
17. Anonymized microdata file of deaths, with cause of death for the year 2006. National Statistics Institute (Instituto Nacional de Estadística - INE), Madrid: INE 2008 http://www.ine.es/
18. Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination. P Beutels, Vaccine 2004 22 25-26 3312 22 10.1016/j.vaccine.2004.03.001 15308354 (Pubitemid 39078747)
19. Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination- a review (2002-2006). P Beutels N Thiry P Van Damme, Vaccine 2007 25 8 1355 67 10.1016/j.vaccine.2006.10.034 17208339 (Pubitemid 46074293)
20. Economic evaluation of pharmaceuticals: science or marketing? MF Drummond, Pharmacoeconomics 1998 14 1 1 9 10.2165/00019053-199814010-00001 10182189 (Pubitemid 28332693)
21. Public advocacy and allocation of federal funds for biomedical research. R Dresser, Milbank Q 1999 77 2 257 74 10.1111/1468-0009.00133 10392164
22. When science offers salvation: patient advocay & research ethics. R Dresser, New York: Oxford University Press 2001
23. Incorporating economic evaluations into decision-making: the Ontario experience. A Laupacis, Med Care 2005 43 suppl 7 15 9 16056004
24. Bias in published cost effectiveness studies: systematic review. CM Bell DR Urbach JG Ray A Bayoumi AB Rosen D Greenberg PJ Neumann, BMJ 2006 332 7543 699 703 10.1136/bmj.38737.607558.80 16495332
25. Using effectiveness and cost-effectiveness to make drug coverage decisions. A Comparison of Britain, Australia, and Canada. FM Clement A Harris JJ Li K Yong KM Lee BJ Manns, JAMA 2009 302 13 1437 43 10.1001/jama.2009.1409 19809025
26. Disease Control Priorities in Developing Countries. DT Jamison JG Breman AR Measham G Alleyne M Claeson DB Evans P Jha A Mills P Musgrove eds, New York: Oxford University Press and The World Bank 2006
27. Priority medicines for Europe and the world. World Health Organization, Geneva: World Health Organization 2004
28. Conflict of interest in industry-sponsored economic evaluations: real or imagined? M Barbieri MF Drummond, Curr Oncol Rep 2001 3 5 410 3 10.1007/s11912-001-0027-2 11489241
29. Summarizing population health: directions for the development and application of population metrics. MJ Field GM Gold eds, Washington DC: National Academy Press 1998
30. Summary measures of population health: concepts, ethics, measurement and applications. CJL Murray JA Salomon CD Mathers AD Lopez eds, Geneva: World Health Organization 2002
31. The comorbidity in primary care. L Palomo C Rubio J Gérvas, Gac Sanit 2006 20 3 17 26 17433197
32. Threads and yarns: weaving the tapestry of comorbidity. B Starfield, Ann Fam Med 2006 4 101 3 10.1370/afm.524 16569711
33. Epidemiological aspects of patient data in Spanish general practice. M Forés J Gérvas M Bonet L Marcos P Toms A Sagués, The International Classification of Primary Care in the European Community Oxford: OUP, Lamberts H, Wood M, Hofmans I, 1993
34. The burden of disease and injury in Australia. CD Mathers ET Vos CE Stevenson SJ Begg, Bull World Health Organ 2001 79 11 1076 84 11731817 (Pubitemid 33078679)